HOME >> BIOLOGY >> NEWS
Scientists discover scaramanga gene's bond with breast cancer

Breakthrough Breast Cancer today announce that UK scientists have discovered that a gene named after the James Bond villain Scaramanga can trigger the development of breasts. This has important implications for breast cancer, as reported in the journal Genes and Development.

During the development of an embryo, formation of organs is tightly controlled by specific genes. In the case of breasts, this process controls the development of two breasts in humans but this can go awry, resulting in fewer, extra or misplaced breasts or nipples. However, little has been known about this how this process is governed, until now.

Today scientists at The Breakthrough Toby Robins Breast Cancer Research Centre, at The Institute of Cancer Research, report that a gene called Scaramanga aptly named after the three-nippled villain from the James Bond film The Man with the Golden Gun is involved in triggering breast development.

"Identifying the Scaramanga gene is a real advance in our understanding of the early steps in breast formation. By learning more about this gene and the protein it produces, it will allow us to determine how normal breast development is initiated and, importantly, examine how this is connected with breast cancer," said Professor Alan Ashworth, Director of The Breakthrough Breast Cancer Research Centre.

By studying abnormal breast development in the lab, scientists at The Breakthrough Breast Cancer Research Centre identified the Scaramanga gene, which regulates the early stages of breast development, and influences the number and position of breasts. The realisation of the importance of their work came when they discovered that the Scaramanga gene produces a protein called NRG3 and that this provides a signal telling embryonic cells to become breast cells. They also showed that a synthetic form of NRG3 was able to initiate the formation of breast cells, confirming the protein's involvement in this intricate process.


'"/>

Contact: Emma Sheppard
emmas@breakthrough.org.uk
44-207-025-2432
Cold Spring Harbor Laboratory
31-Aug-2005


Page: 1 2

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Scientists move closer to bio-engineered bladders
4. Scientists find stem cell switch
5. Scientists discover new way to study nanostructures
6. Scientists a step closer to understanding how anaesthetics work in the brain
7. Scientists to make news at Computational Biology Conference
8. Accident-prone? Scientists link brain function to knee injuries
9. Scientists take next step in understanding potential target for ovarian cancer treatment
10. Scientists find brown fat master switch
11. Scientists identify 2 distinct Parkinsons networks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... SOUTH JORDAN, Utah and BOSTON (PRWEB) , ... ... ... CallTower , a global leader in delivering cloud-based enterprise-class unified ... CT Cloud Boost delivers enhanced network stability by directly connecting CallTower data ...
(Date:10/13/2018)... ... October 12, 2018 , ... HOLLOWAY ... a booth at premier packaging event PACK EXPO International in Chicago from October ... Institute (PMMI), of which HOLLOWAY AMERICA is a member. , At this year’s ...
(Date:10/11/2018)... ... October 09, 2018 , ... ... life science and biotechnology companies, announced today that it will host a ... their investment philosophies, explain their fund and deal structures, and describe how ...
Breaking Biology News(10 mins):
(Date:9/28/2018)... ... September 28, 2018 , ... GlycoMark®, Inc. ... availability of the GlycoMark test, the only FDA-cleared blood test specific to detecting ... will promote and offer the GlycoMark test to its network of physicians through ...
(Date:9/27/2018)... ... September 26, 2018 , ... NDA Partners ... a senior quality, regulatory, and in vitro diagnostic device expert with more than ... has joined the firm as an Expert Consultant. Her experience includes leadership roles ...
(Date:9/27/2018)... ... 26, 2018 , ... Medable was named DPharm Idol at ... first human digitome, a digital representation of human health and disease, by removing ... all data sources. Dr. Michelle Longmire, Co-Founder and CEO of Medable, explained that ...
(Date:9/27/2018)... ... September 27, 2018 , ... This past weekend at ... Mobile Technology, Inc. announced they will formally merge companies and integrate their technologies ... (TB) and other diseases. These two social enterprise corporations, both of which focus ...
Breaking Biology Technology:
Cached News: